ClinicalTrials.gg
CompletedNCT01796054SFN-NursesUpdated May 11, 2022

Stress Free Now, a Mind-body Reduction Program for Nurses

An interventional study of Stress Free Now online program and Group support session in Psychological Stress, Anxiety and Depression, sponsored by The Cleveland Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-11.

Sponsored by The Cleveland Clinic · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
360
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Mindful meditation sessions have been associated with an improvement in mindfulness, perceived stress, psychological well-being, anxiety, hostility, and depression. Meditation has been associated with a decrease in autonomic sympathetic activity, heart rate, oxygen consumption and energy expenditure. Randomized controlled trials of online mindfulness and relaxation programs have been studied in patients with conditions such as irritable bowel syndrome, headache, depression, fibromyalgia, and insomnia. Nurses may benefit from such programs given levels of job stress. This study will determine whether an online stress reduction program that incorporates meditation with and without concomitant group support reduces burnout among nurses, including emotional exhaustion and depersonalization. The proposed research study will utilize Stress Free Now, an online stress reduction program developed by Cleveland Clinic Wellness Institute.

Read the detailed description

This is a randomized, controlled, single-center research study of an online intervention with peer group support to reduce stress in nurses. All participants will be assigned to the intervention or control groups by random number allocation. The duration of the intervention is 6 weeks; follow-up is at 6 and 24 weeks; the duration of the study is 6 months (24 weeks). Total individual participant time commitment will depend on particular intervention or control group assignment. Both intervention and control groups will be requested to complete a set of questionnaires at weeks 0, 6, and 24. The questionnaires will take an estimated 45 minutes to complete.

02

Conditions studied

  • Psychological Stress
  • Anxiety
  • Depression

Keywords

  • Perceived stress
  • Burnout
  • Mindfulness
  • Intent to leave nursing
03

In context

Stress, Psychological

806 studies on the registry are indexed under Stress, Psychological; 131 are open to participants now.

This study's enrollment of 360 is above the median of 84 across 651 interventional studies indexed under Stress, Psychological.

Browse Stress, Psychological studies →

Lead sponsor

The Cleveland Clinic is the lead sponsor of 831 studies on the registry; 119 are open to participants now.

Of its 90 completed or terminated interventional studies of FDA-regulated products, 73 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • be at least 18 years of age
  • work as a full-time or part-time nurse at Cleveland Clinic
  • have regular internet and email access and be willing and able to attend group support sessions
  • work at least one weekday during the week in order to attend orientation and/or group support sessions

Exclusion criteria

Exclusion Criteria:

  • participating in another stress reduction research study
  • pregnant, lactating, or planning to be pregnant in the next 6 months
  • hospitalized for depression in past 12 months
  • vacation time away from work for more than 1 week during the first 2 months of the study
  • current diagnosis of schizophrenia, other psychotic or bipolar disorder
  • other medial, psychiatric, or behavioral limitations that may interfere with study participation or the ability to follow the intervention protocol
  • unwilling or uninterested in participating in group sessions
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
360 participants (actual)

Study arms

  • Experimental
    Stress Free Now with group support

    Randomized participants have access to online stress reduction program, Stress Free Now. Participants will log in to online program, read daily lessons and practice therapeutic exercises. They will also attend weekly group support session during 6-week program

    Behavioral: Stress Free Now online program · Behavioral: Group support session

  • Experimental
    Stress Free Now

    Randomized participants have access to online stress reduction program, Stress Free Now, for 6 weeks. Participants will log into online program, read daily lessons and practice therapeutic exercises.

    Behavioral: Stress Free Now online program

  • No intervention
    Control

    Randomized participants do not have access to online stress reduction program, Stress Free Now, nor do they attend weekly group support sessions.

Interventions

  • BehavioralStress Free Now online program

    Stress Free Now is an online stress reduction program. Participants will log into online program, read and practice daily and weekly activities.

  • BehavioralGroup support session

    Participants will meet weekly for group support session to review online lessons and relaxation therapies.

06

What researchers measure

Primary outcomes

  1. Burnout

    Measured by Maslach Burnout Inventory Human Services Survey

    Time frame: 24 weeks

Secondary outcomes

  1. Perceived stress

    Measured by Perceived Stress Scale

    Time frame: 24 weeks

  2. Self-reported BMI

    Time frame: 24 weeks

  3. Emotional well-being

    Measured by RAND Short-Form (SF)-36

    Time frame: 24 weeks

  4. Insomnia

    Time frame: 24 weeks

  5. Psychosomatic symptoms

    Measured by Psychosomatic Symptoms Checklist

    Time frame: 24 weeks

  6. Mindfulness

    Measured by Five Factor Mindfulness Questionnaire

    Time frame: 24 weeks

  7. Intent to leave nursing

    Time frame: 24 weeks

07

Study locations

1 site
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2013, a primary completion of Aug 2014 and a completion of Aug 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 15, 2013
First posted
Feb 21, 2013
Start
Feb 2013
Primary completionActual
Aug 2014
CompletionActual
Aug 2014
Last update
May 11, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01796054
Responsible party
Linda Libertini (Research Coordinator, The Cleveland Clinic) — Principal investigator
First posted
Feb 21, 2013
Start date
Feb 2013
Primary completion
Aug 2014
Completion
Aug 2014
Last update
May 11, 2022

Study contacts

Adam Bernstein, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion